Lupin Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products".
Lupin Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products".